arrow
Y

Yves Gruel

Inserm
H指数:47
被引数:7,364

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2026-09-040
OA
Anticoagulant management in emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP)*

急诊抗凝管理:2024年法国急诊医学学会(SFMU)、法国麻醉与重症监护医学学会(SFAR)、法国血栓与止血学会(SFTH)及法国围手术期止血工作组(GIHP)指南*

2025-06-260
PRE
Clinical, Phenotypic and Genotypic Characteristics of Von Willebrand Disease in Afro-Caribbeans: Results From a Study in Martinique Island, French West Indies
2025-03-010
OA
Anti-Phospholipid Syndrome (APS) Antibody (Ab)-Induced Thrombosis Can be Blocked By Platelet Factor 4 (PF4)-Directed Abs: A Novel Therapeutic Approach for APS?

抗磷脂综合征(APS)抗体(Ab)诱导的血栓可通过血小板因子4(PF4)定向抗体(Abs)阻断:这是APS的一种新型治疗策略?

BLOOD
IF23.1
2024-11-050
PRE
The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia
2024-08-012
OAAI
Vascular endothelial growth factor, tissue factor, coagulation and fibrinolysis markers in slow-flow vascular malformations: a prospective study of treatment with sirolimus
2022-11-051
PRE
Management of urgent invasive procedures in patients treated with direct oral anticoagulants: An observational registry analysis
2022-08-019
OAAI
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
2022-07-1810
OAAI
Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology
2022-01-016
PRE
GFHT proposals on the practical use of argatroban - With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)
2021-12-018
PREAI